3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Ketosis
1
Insulin Resistance
1
Glioma
1
Glioblastoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Temozolomide
66
Radiotherapy
52
Carboplatin
25
Bevacizumab
21
Cisplatin
19
Radiosurgery
18
Vincristine
17
Etoposide
17
Cyclophosphamide
17
Surgical Procedures, Operative
13
Magnetic Resonance Spectroscopy
13
Chemotherapy, Adjuvant
11
Melphalan
10
Lomustine
10
Drug Therapy
10
Filgrastim
9
Erlotinib Hydrochloride
9
apatinib
8
Pemetrexed
8
3-Iodobenzylguanidine
8
anlotinib
7
Radiation
7
Peripheral Blood Stem Cell Transplantation
7
Methotrexate
7
Thiotepa
6
Isotretinoin
6
Irinotecan
6
Ifosfamide
6
Doxorubicin
6
Carmustine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hypoglycemic Agents
×
CNS
×
Clear all
NCT02149459
2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1
Unknown
18 enrolled